TY - JOUR
T1 - Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
AU - Stelken, Arthur M.
AU - Younis, Liwa T.
AU - Jennison, Stephen H.
AU - Miller, D. Douglas
AU - Miller, Leslie W.
AU - Shaw, Leslee J.
AU - Kargl, Debra
AU - Chaitman, Bernard R.
PY - 1996/2
Y1 - 1996/2
N2 - Objectives. We tested the hypothesis that percent achieved of predicted peak oxygen uptake (predicted V̇O2(max)) improves the prognostic accuracy of identifying high risk ambulatory patients with congestive heart failure considered for heart transplantation compared with absolute peak oxygen uptake (V̇O2(max)) in 181 patients with ischemic or dilated cardiomyopathy. Background. Peak oxygen uptake during exercise has been shown to be a useful prognostic measurement to risk stratify patients with heart failure. The prognostic value of percent predicted V̇O2(max) has not been assessed in these patients. Methods. We retrospectively studied 181 ambulatory patients referred to the Saint Louis University Heart Failure Unit. Clinical, hemodynamic (137 patients) and coronary angiographic (145 patients) data were recorded, and all patients underwent symptom-limited cardiopulmonary exercise. Results. During a mean follow-up period of 12 ± 6 months, 26 patients died, and 18 were listed as Status 1 priority for heart transplantation. The actuarial 1- and 2-year survival of the 89 patients who achieved ≤50% predicted V̇O2(max) was 74% and 43%, respectively, compared with 98% and 90% in the 92 who achieved >50% predicted V̇O2(max) (p = 0.001). Multivariable analysis selected ≤50% predicted V̇O2(max) as the most significant predictor of cardiac death (p = 0.007) and cardiac death or Status 1 priority (P = 0.0005). Conclusions. Percent achieved of predicted V̇O2(max) provides important information that can be used to risk stratify ambulatory patients with heart failure with ischemic or dilated etiology that exceeds that provided by measurement of V̇O2(max) alone. Patients who achieve >50% predicted V̇O2(max) have an excellent short-term prognosis when treated medically, and heart transplantation can be safely deferred.
AB - Objectives. We tested the hypothesis that percent achieved of predicted peak oxygen uptake (predicted V̇O2(max)) improves the prognostic accuracy of identifying high risk ambulatory patients with congestive heart failure considered for heart transplantation compared with absolute peak oxygen uptake (V̇O2(max)) in 181 patients with ischemic or dilated cardiomyopathy. Background. Peak oxygen uptake during exercise has been shown to be a useful prognostic measurement to risk stratify patients with heart failure. The prognostic value of percent predicted V̇O2(max) has not been assessed in these patients. Methods. We retrospectively studied 181 ambulatory patients referred to the Saint Louis University Heart Failure Unit. Clinical, hemodynamic (137 patients) and coronary angiographic (145 patients) data were recorded, and all patients underwent symptom-limited cardiopulmonary exercise. Results. During a mean follow-up period of 12 ± 6 months, 26 patients died, and 18 were listed as Status 1 priority for heart transplantation. The actuarial 1- and 2-year survival of the 89 patients who achieved ≤50% predicted V̇O2(max) was 74% and 43%, respectively, compared with 98% and 90% in the 92 who achieved >50% predicted V̇O2(max) (p = 0.001). Multivariable analysis selected ≤50% predicted V̇O2(max) as the most significant predictor of cardiac death (p = 0.007) and cardiac death or Status 1 priority (P = 0.0005). Conclusions. Percent achieved of predicted V̇O2(max) provides important information that can be used to risk stratify ambulatory patients with heart failure with ischemic or dilated etiology that exceeds that provided by measurement of V̇O2(max) alone. Patients who achieve >50% predicted V̇O2(max) have an excellent short-term prognosis when treated medically, and heart transplantation can be safely deferred.
UR - http://www.scopus.com/inward/record.url?scp=0030044971&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030044971&partnerID=8YFLogxK
U2 - 10.1016/0735-1097(95)00464-5
DO - 10.1016/0735-1097(95)00464-5
M3 - Article
C2 - 8557904
AN - SCOPUS:0030044971
SN - 0735-1097
VL - 27
SP - 345
EP - 352
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 2
ER -